HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

The impact of parenteral narcotic choice in the development of acute chest syndrome in sickle cell disease.

AbstractBACKGROUND:
Acute chest syndrome (ACS) represents a serious morbidity and often fatal complication in patients with sickle cell disease. Painful episodes which require hospitalization are most often treated with opioids, which may then influence the development of ACS. Nalbuphine is a parenteral opioid which effectively treats pain and may cause less ACS.
PROCEDURE:
This retrospective chart review documented 988 admissions for painful episodes at 2 institutions and recorded the incidence of ACS and opioid used.
RESULTS:
At the Children's Hospital in St Louis, Missouri, the incidence of ACS in patients treated with morphine alone was 10.8% versus at the Children's Mercy Hospital in Kansas City, Missouri, the incidence was 2.1% for patients treated solely with nalbuphine.
CONCLUSIONS:
When nalbuphine is used alone as the single parenteral opioid agent to treat painful episodes in patients with sickle cell disease, the incidence of ACS is less than when compared with other opioids used to treat pain.
AuthorsKaren Lewing, Kristen Britton, Michael DeBaun, Gerald Woods
JournalJournal of pediatric hematology/oncology (J Pediatr Hematol Oncol) Vol. 33 Issue 4 Pg. 255-60 (May 2011) ISSN: 1536-3678 [Electronic] United States
PMID21464764 (Publication Type: Comparative Study, Journal Article)
Chemical References
  • Narcotics
  • Morphine
  • Nalbuphine
Topics
  • Acute Disease
  • Adolescent
  • Anemia, Sickle Cell (epidemiology)
  • Chest Pain (chemically induced, drug therapy, epidemiology)
  • Child
  • Child, Preschool
  • Choice Behavior
  • Female
  • Humans
  • Incidence
  • Male
  • Morbidity
  • Morphine (administration & dosage, adverse effects)
  • Nalbuphine (administration & dosage, adverse effects)
  • Narcotics (administration & dosage, adverse effects)
  • Parents
  • Retrospective Studies
  • Young Adult

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password: